Fig. 1From: Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis BThe cumulative rate of virological and clinical relapse after cessation of nucleos(t)ide analogue (NA) treatment for 240 weeks. a Frequency of patients in sustained response, virological relapse and clinical relapse at different timepoints. b The cumulative rate of virological relapse in all patients. c The cumulative rate of clinical relapse in all patientsBack to article page